Beijing-based Linkerbot, which holds 80%+ of the global market in dexterous robotic hands, raised a Series B+ at a $3B valuation and seeks a $6B valuation next
Context & Ripple Effects
Linkerbot’s financing arrives amid a run of large private rounds for Chinese robotics companies, including humanoid-focused Robotera and Galbot and AI² Robotics and X Square Robot. The common thread is not only investment in complete robots, but rising valuations across the enabling stack.
Linkerbot stands out within that coverage because it is described as controlling more than 80% of the global market for dexterous robotic hands—a specialized component layer that can matter to multiple robot makers rather than a single robot platform.
First-order effects
- The Series B+ gives Linkerbot additional capital at a $3B valuation while setting a public benchmark for its proposed next-round valuation of $6B.
- A supplier with a stated dominant share in dexterous hands is better positioned to fund product development and capacity for customers building humanoid or other manipulation-capable robots.
Second-order effects
- Robot makers and competing manipulation-component suppliers will face a clearer capital and valuation benchmark as investors compare them with a well-funded category leader.
- If Linkerbot’s share persists, robot developers may become more dependent on a concentrated hand-supply layer, increasing the strategic value of alternative suppliers and in-house development.
Third-order effects
- The robotics investment cycle may increasingly assign platform-scale value to bottleneck components, not just to companies assembling full humanoid systems.
- If high valuations continue to accrue to both robot makers and key subsystem suppliers, the sector could develop around a smaller number of heavily financed component champions alongside competing robot platforms.
The trend: This is one data point in the capitalization of the humanoid-robotics supply chain, where dexterous manipulation is emerging as a strategically valuable layer.